MELPHALAN VS POLYMELPHALANUM IN OVARIAN CANCER-PATIENTS RESISTANT TO CYCLOPHOSPHAMIDE - TENTATIVE STATISTICAL APPROACH TO BALANCE RISKS AND BENEFITS

被引：2

作者：

MORASCA, L

RECCHIA, M

GRAMELLINI, E

BOLIS, G

MANGIONI, C

机构：

[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

[2] UNIV MILAN,OBSTET & GYNECOL CLIN 1,I-20100 MILAN,ITALY

来源：

EUROPEAN JOURNAL OF CANCER | 1977年 / 13卷 / 08期

关键词：

D O I：

10.1016/0014-2964(77)90136-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：817 / 820

页数：4

共 12 条

[1]

ASTALDI G, 1972, TERAPIA, V57, P163

[2]

BERGEL F, 1961, BIOLOGICAL APPROACHE, P125

[3]

BERGSAGEL DE, 1972, CAN MED ASSOC J, V107, P851

[4]

DEBARBIERI A, 1972, ATTI S PEPTICHEMIO, P14

[5]

LARIONOV LF, 1957, DOKL AKAD NAUK SSSR+, V114, P1070

[6]

LOVINA TECLA O., 1962, CANCER CHEMOTHER REPTS, V23, P39

[7] CONTINUOUS LOW-DOSE CYCLOPHOSPHAMIDE (NSC-26271) THERAPY IN ADVANCED OVARIAN CANCER [J].

MANGIONI, C ;

BOLIS, G ;

NATALE, N ;

MORASCA, L .

EUROPEAN JOURNAL OF CANCER, 1976, 12 (05) :353-356

[8]

MASSIMO L, 1971, Bollettino Societa Italiana Biologia Sperimentale, V50, P341

[9]

NATALE N, 1972, ATTI S PEPTICHEMIO, P246

[10]

PIVER MS, 1975, CANCER CHEMOTH REP 1, V59, P1157

← 1 2 →